| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.3715 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.3801 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.3902 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.3955 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.4141 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.4172 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.4440 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.4467 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5106 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5219 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5274 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5298 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5338 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5724 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5769 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5823 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6179 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6337 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6390 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6408 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6554 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6598 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6764 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6767 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6909 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7044 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7113 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7246 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7345 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7377 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7461 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7483 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7632 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7660 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7711 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7860 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7965 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8085 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8118 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8127 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8234 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8237 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8250 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8272 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8332 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8401 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8533 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8537 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8607 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8759 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8772 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8825 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8838 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8847 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8986 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9014 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9049 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9227 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9305 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9321 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9332 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9383 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9687 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9765 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9897 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0000 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0028 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0206 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0213 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0261 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0582 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0585 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0668 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0763 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0878 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1253 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1450 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1498 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1621 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1727 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1780 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1836 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1864 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2027 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2068 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2079 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2116 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2158 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2203 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2481 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2638 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2672 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2742 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2940 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3008 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3030 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3320 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3594 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3631 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3658 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4102 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4207 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4531 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4688 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4699 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4767 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4918 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5215 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5998 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6484 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6485 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6504 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6738 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7053 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7373 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7580 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7752 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7986 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8288 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8687 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8976 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.9275 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.0866 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.5539 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.5981 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.6309 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.9933 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 3.3494 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 3.4054 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 4.8599 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 4.9812 | Peak area | Obese neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|